Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen

Clinical trial NCT02274259 · COMPLETED

Trial details

NCT number: NCT02274259
Sponsor: Anders Kvanta
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Central Retinal Vein Occlusion

Start date: 2014-10-01
Primary completion: 2015-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.